Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease

American Journal of Kidney Diseases

Volumn 34, Issue 2, 1999, Pages 273-278

  Perez Oller, L ^a   Torra, R ^a   Badenas, C ^a   Mila, M ^a   Darnell, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Angiotensin converting enzyme gene; Autosomal dominant; End stage renal disease; Hypertension; Polycystic; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; DISEASE COURSE; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROGNOSIS; SURVIVAL;

EID: 0032781703     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70355-0     Document Type: Article

References (34)

1. C García Iglesias VE Torres KP Offord KE Holley OM Beard LT Karland Epidemiology of adult polycystic kidney disease; Olmsted County, Minessota 1935-1980 Am J Kidney Dis 2 1983 630 639
2. PA Gabow AM Johnson WD Kaehny WJ Kimberling DC Lezotte IT Duley RH Jones Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease Kidney Int 41 1992 1311 1319
3. PA Gabow JJ Grantham Polycystic kidney disease ed 5 RW Shrier CW Gottschalk Diseases of the Kidney 1993 MA, Little, Brown Boston 535 569
4. GM Fick AM Johnson JD Strain WJ Kimberling S Kumer ML Manco-Johnson IT Duley PA Gabow Characteristics of very early-onset autosomal dominant polycystic kidney disease J Am Soc Nephrol 3 1993 1863 1870
5. DJM Peters LA Sandkuijl JJ Saris L Spruit RG Elles S Pound A Wright S Jeffery LP Lazaron P Girginoudis L Bachner C Terec P Mandich A Turco G Restagno L Veneziano B Peral JL San Millan S Norby R Fossdal MH Breuning Genetic heterogeneity of polycystic kidney disease in Europe Contrib Nephrol 97 1992 128 139
6. MC Daoust DM Reynolds DG Bichet S Somlo Evidence for a third genetic locus for autosomal dominant polycystic kidney disease Genomics 25 1995 733 736
7. N Bogdanova B Dworniczak D Dragova V Todorov D Dimitrakov K Kalinov J Hallmayer J Horst L Kalaydjieva Genetic heterogeneity of polycystic kidney disease in Bulgaria Hum Genet 95 1995 645 650
8. S De Almeida E De Almeida D Peters JR Pinto I Tavora J Lavinha M Breuning MM Prata Autosomal dominant polycystic kidney disease: Evidence for the existence of a third locus in a Portuguese family Hum Genet 96 1995 83 88
9. R Torra C Badenas A Darnell C Nicolau V Volpini L Revert X Estivill Linkage, clinical features and prognosis of autosomal dominant polycystic kidney disease types 1 and 2 J Am Soc Nephrol 7 1996 2142 2151
10. B Rigat C Hubert F Alhenc-Gelas F Cambien P Corvol F Soubrier An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounts for half the variance of serum enzyme levels J Clin Invest 86 1990 1343 1346
11. CRK Dudley B Keavney IM Stratton RC Turner PJ Ratcliffe UK Prospective Diabetes Study XV : Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM Kidney Int 48 1995 1907 1911
12. PN Harden C Geddes PA Rowe JH McIlroy M Bulton-Jones RS Rodger BJ Junor JD Briggs JM Connell AG Jardine Polymorphisms in angiotensin-converting enzyme gene and progression of IgA nephropathy Lancet 345 1995 1540 1542
13. P Fernández-Llama E Poch J Oriola A Botey E Coll A Darnell F Rivera L Revert Angiotensin-converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis Kidney Int 53 1998 1743 1747
14. A Schmidt HP Kiener U Bernas I Arias A Illierich M Auinger W Graninger A Kaider G Mayer Angiotensin-converting enzyme polymorphism in patients with terminal renal failure J Am Soc Nephrol 7 1996 314 317
15. ML Watson AM Macnicol PL Allan AF Wright Effects of angiotensin-converting enzyme inhibition in adult polycystic kidney disease Kidney Int 41 1992 206 210
16. D Ravine RN Gibson RG Walker LJ Sheffield P Kincaid-Smith DM Danks Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1 Lancet 343 1994 824 827
17. V Shanmugann KW Sell BK: Saha ACE Mistyping heterozygotes PCR Methods Applications 3 1993 120 121
18. D Collect Modelling Survival Data in Medical Research 1994 Chapman & Hall London, UK
19. L Tiret F Kee O Poirier V Nicaud L Lecerf A Evans JP Cambou D Arveiler G Luc P Amouyel F Cambien Deletion polymorphism in the angiotensin-converting enzyme gene associated with parental history of myocardial infarction Lancet 341 1993 991 992
20. H Schunkert H Hans-Werner SR Holmes M Stender S Perz U Keil BH Lorell GAJ Riegger Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy N Engl J Med 330 1994 1634 1638
21. JW Brock III M Adams T Hunley A Wada L Trusler V Kon Potential risk factors associated with progressive renal damage in childhood urological diseases: The role of angiotensin-converting enzyme gene polymorphism J Urol 158 1997 1308 1311
22. J Norman B Badie-Dezfooly EP Nord I Kurtz J Schlosser A Chaudhari LG Fine EGF-induced mitogenesis in proximal tubular cells: Potentiation by angiotensin II Am J Physiol 253 1987 F299 F309
23. VE Torres TJ Berndt M Okamura JW Nesbit KE Holley FA Carone FA Knox JC Romero Mechanisms affecting the development of renal cystic disease induced by diphenylthiazole Kidney Int 33 1988 1130 1139
24. PA Wilson AC Sherwood Tubulocystic epithelium Kidney Int 39 1991 450 463
25. VE Torres KA Donovan G Scicli KE Holley SN Thibodeau OA Carretero T Inagami JA McAteer CM Johnson Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease Kidney Int 42 1992 364 373
26. GM Fick AM Johnson WS Hammond PA Gabow Causes of death in autosomal dominant polycystic kidney disease J Am Soc Nephrol 5 1995 2048 2056
27. PE Bell KF Hossack PA Gabow JA Durr AM Johnson RW Schrier Hypertension in autosomal dominant polycystic kidney disease Kidney Int 34 1988 683 690
28. PA Gabow AB Chapman AM Johnson DJ Tangel IT Duley WD Kaehny M Manco-Johnson RW Schrier Renal structure and hypertension in autosomal dominant polycystic kidney disease Kidney Int 38 1990 1177 1180
29. K Baboolal D Ravine J Daniels N Williams P Holmans GA Coles JD Williams Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease Kidney Int 52 1997 607 613
30. J Uemasu A Nakaoka H Kawasaki I Ishikawa Y Yoshino H Shio R Nemoto I Nakamura S Morio Association between angiotensin-converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease Life Sci 60 1997 2139 2144
31. AE Turco E Bresin S Rossetti S Englisch PF Pignatti L Gammaro G Maschio M Bendetti M Li Vecchi A Ferrantelli G Cerasola B Stiasny B Schulze Molecular genetic investigations in autosomal dominant polycystic kidney disease. Gene mutation detection, linkage analysis and preliminary ACE gene I/D polymorphism association studies: An update Contrib Nephrol 122 1997 53 57
32. T Moriyama H Kitamura S Ochi M Izumi K Yokoyama A Yamauchi N Ueda T Kamada E Imai Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria J Am Soc Nephrol 6 1995 1674 1678
33. DS Keith VE Torres CM Johnson KE Holley Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats Am J Kidney Dis 24 1994 491 498
34. SA Ritter G Baehr The arterial supply of the congenital polycystic kidney and its relation to the clinical picture J Urol 21 1929 583 591